Omeros (OMER) Revenue (QoQ) (2010 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 4.10% |
| Jun 30, 2021 | 36.85% |
| Mar 31, 2021 | 98.09% |
| Dec 31, 2020 | -59.29% |
| Sep 30, 2020 | 93.01% |
| Jun 30, 2020 | -42.52% |
| Mar 31, 2020 | -29.57% |
| Dec 31, 2019 | 11.93% |
| Sep 30, 2019 | 11.60% |
| Jun 30, 2019 | 22.84% |
| Mar 31, 2019 | -1.08% |
| Dec 31, 2018 | 377.80% |
| Sep 30, 2018 | 178.43% |
| Jun 30, 2018 | 4.22% |
| Mar 31, 2018 | -88.46% |
| Dec 31, 2017 | -36.47% |
| Sep 30, 2017 | 26.28% |
| Jun 30, 2017 | 39.93% |
| Mar 31, 2017 | -5.02% |
| Dec 31, 2016 | 14.31% |
| Sep 30, 2016 | 12.84% |
| Jun 30, 2016 | 34.84% |
| Mar 31, 2016 | 11.15% |
| Dec 31, 2015 | 104.82% |
| Sep 30, 2015 | 2.26% |
| Jun 30, 2015 | 721.39% |
| Mar 31, 2015 | 115.56% |
| Dec 31, 2014 | -15.89% |
| Sep 30, 2014 | 375.56% |
| Jun 30, 2014 | -55.00% |
| Mar 31, 2014 | -40.83% |
| Dec 31, 2013 | -13.78% |
| Sep 30, 2013 | 40.00% |
| Jun 30, 2013 | -87.21% |
| Mar 31, 2013 | -30.83% |
| Dec 31, 2012 | 11.71% |
| Sep 30, 2012 | -7.14% |
| Jun 30, 2012 | 2.01% |
| Mar 31, 2012 | 30.88% |
| Dec 31, 2011 | 15.81% |
| Sep 30, 2011 | -14.55% |
| Jun 30, 2011 | -6.78% |
| Mar 31, 2011 | 26.95% |
| Dec 31, 2010 | 284.25% |
| Sep 30, 2010 | -48.89% |